Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EPS (Basic) (2019 - 2025)

IDEAYA Biosciences' EPS (Basic) history spans 7 years, with the latest figure at -$0.94 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 39.35% year-over-year to -$0.94; the TTM value through Dec 2025 reached -$1.28, up 61.9%, while the annual FY2025 figure was -$1.28, 61.9% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.94 at IDEAYA Biosciences, down from $1.35 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.35 in Q3 2025 and bottomed at -$1.55 in Q4 2024.
  • The 5-year median for EPS (Basic) is -$0.51 (2023), against an average of -$0.47.
  • The largest annual shift saw EPS (Basic) crashed 1250.0% in 2023 before it soared 325.0% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.49 in 2021, then decreased by 10.2% to -$0.54 in 2022, then rose by 3.7% to -$0.52 in 2023, then crashed by 198.08% to -$1.55 in 2024, then soared by 39.35% to -$0.94 in 2025.
  • Per Business Quant, the three most recent readings for IDYA's EPS (Basic) are -$0.94 (Q4 2025), $1.35 (Q3 2025), and -$0.87 (Q2 2025).